Serial 79189283
Live / Registered — Registered — Section 71 accepted (as of 23 Jun 2023)
What this means for you
Registered since 13 Dec 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use was filed 17 Oct 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 79189283
- Registration number
- 5098016
- Mark type
- Design / logo
- Filed
- 06 Apr 2016
- Published for opposition
- 27 Sept 2016
- Registered
- 13 Dec 2016
- Next maintenance filing
- §71 ten-year affidavit of use, filed 17 Oct 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] Pharmaceutical products for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 17 Oct 2026 — TEAS SECTION 71 RECEIVED
- 19 Mar 2026 — INTERNATIONAL REGISTRATION RENEWED
- 13 Dec 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 25 Mar 2024 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 29 Feb 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 29 Feb 2024 — INVALIDATION PROCESSED
- 23 Feb 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 23 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 23 Jun 2023 — REGISTERED-SEC.71 ACCEPTED
- 23 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Dec 2022 — TEAS SECTION 71 RECEIVED
- 13 Dec 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 08 Apr 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Mar 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Mar 2017 — FINAL DISPOSITION PROCESSED